학술논문
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial
Document Type
Article
Author
Choudhary, M.C.; Deo, R.; Flynn, J.P.; Regan, J.; Crain, C.R.; Li, J.Z.; Chew, K.W.; Currier, J.S.; Moser, C.; Hughes, M.D.; Ritz, J.; Giganti, M.; Ribeiro, R.M.; Ke, R.; Perelson, A.S.; Dragavon, J.A.; Greninger, A.L.; Coombs, R.W.; Dragavon, J.; Javan, A.C.; Nirula, A.; Klekotka, P.; Fletcher, C.V.; Daar, E.S.; Corado, K.; Wohl, D.A.; Eron, J.J.; Fischer, W.; Newell, M.; Pedersen, S.; Parikh, U.M.; Sieg, S.F.; Smith, D.M.; Smith, D.D.; Javan, A.C.; Hosey, L.; Roa, J.; Patel, N.; Shahkolahi, A.; Colsh, K.; Rwakazina, I.; Beck, J.; Evering, T.; Ignacio, R.B.; Cardoso, S.; Jagannathan, P.; Singh, U.; Jilg, N.; Pillay, S.; Riviere, C.; Taiwo, B.; Gottesman, J.; Jennings, C.; Greenfelder, B.; Murtaugh, W.; Kosmyna, J.; Gapara, M.
Source
In: Nature Microbiology . (Nature Microbiology, November 2022, 7(11):1906-1917)
Subject
Language
English
ISSN
20585276